CINXE.COM

Pharmafocus - Magazine Issues

<!DOCTYPE html><html lang="en"><head><link rel="stylesheet" data-href="https://fonts.googleapis.com/css?family=Trade+Gothic+Lt+Bold%7COpen+Sans%7CTrade+Gothic+Lt&amp;display=swap" data-optimized-fonts="true"/><title>Pharmafocus - Magazine Issues</title><link rel="icon" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png"/><link rel="shortcut icon" type="image/x-icon" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png?optimizer=image&amp;format=webp&amp;width=180&amp;aspectRatio=1"/><link rel="apple-touch-icon" sizes="180x180" href="https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png?optimizer=image&amp;format=webp&amp;width=180&amp;aspectRatio=1"/><meta name="application-name" content="Pharmafocus - Magazine Issues"/><meta name="apple-mobile-web-app-capable" content="yes"/><meta name="apple-mobile-web-app-status-bar-style" content="default"/><meta name="apple-mobile-web-app-title" content="Pharmafocus - Magazine Issues"/><meta name="format-detection" content="telephone=no"/><meta name="mobile-web-app-capable" content="yes"/><meta name="msapplication-TileColor" content="#1976D2"/><meta name="msapplication-tap-highlight" content="no"/><link rel="manifest" href="/manifest.json"/><meta name="twitter:url" content="https://www.pharmafocus.com"/><meta name="theme-color" content="#1976D2"/><meta name="viewport" content="width=device-width, initial-scale=1"/><meta charSet="utf-8"/><meta itemProp="name" content="Pharmafocus - Magazine Issues"/><meta itemProp="description" content="Pharmafocus - Magazine Issues"/><meta name="description" content="Pharmafocus - Magazine Issues"/><meta itemProp="image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta property="og:description" content="Pharmafocus - Magazine Issues"/><meta property="og:title" content="Pharmafocus - Magazine Issues"/><meta property="og:site_name" content="Pharmafocus - Magazine Issues"/><meta property="og:image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta property="og:type" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="Pharmafocus - Magazine Issues"/><meta name="twitter:description" content="Pharmafocus - Magazine Issues"/><meta name="twitter:image" content="https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png"/><meta name="twitter:site" content="@Pharmafocus"/><meta name="twitter:creator" content="@Pharmafocus"/><style>html{--heading-font: &quot;Trade Gothic Lt Bold&quot;;--body-font: &quot;Open Sans&quot;;--ui-font: &quot;Trade Gothic Lt Bold&quot;;--top-menu-title-font: &quot;Trade Gothic Lt Bold&quot;;--top-menu-subtitle-font: &quot;Trade Gothic Lt&quot;;--top-menu-items-font: &quot;Trade Gothic Lt&quot;;--footer-menu-title-font: &quot;Trade Gothic Lt Bold&quot;;--footer-menu-items-font: &quot;Trade Gothic Lt Bold&quot;;--background-color: #FFFFFF;--background-color-dark: #808080;--primary-color: #1976D2;--primary-color-dark: #0C3B69;--secondary-color: #795FF4;--secondary-color-dark: #250B9F;--accent-color: #D76FD6;--accent-color-dark: #80237F;--info-color: #41638C;--info-color-dark: #213246;--warning-color: #EF9338;--warning-color-dark: #89490B;--success-color: #20AD27;--success-color-dark: #105714;--danger-color: #DF4241;--danger-color-dark: #7B1515;--top-menu-background-color: #EE1C25;--top-menu-background-color-dark: #7C090E;--footer-menu-background-color: #DF1111;--footer-menu-background-color-dark: #6F0808;--navbar-height: 64px; }</style><link rel="stylesheet" href="https://cdn.magloft.com/reader/fonts/trade-gothic-lt.css"/><link rel="stylesheet" href="https://cdn.magloft.com/reader/fonts/trade-gothic-lt-bold.css"/><script type="text/javascript" src="https://cdn.jsdelivr.net/npm/cookie-bar/cookiebar-latest.min.js?customize=1&amp;always=1&amp;showNoConsent=1"></script><meta name="google-site-verification" content="kuOvGxaH_NjG3aS7GSmbjjV-OjdOAWyiM3gEPGESeHQ"/><style> #billboard-banner { text-align:center;} #billboard-banner img {width:100%; max-width:970px; height:auto; position:relative; top:70px;} .Layout_spacer__qTBD3 {margin-top:70px;} </style><meta name="next-head-count" content="39"/><link rel="preconnect" href="https://fonts.googleapis.com"/><link rel="preconnect" href="https://fonts.gstatic.com"/><link rel="preload" href="/_next/static/css/229efe2956472d85.css" as="style"/><link rel="stylesheet" href="/_next/static/css/229efe2956472d85.css" data-n-g=""/><link rel="preload" href="/_next/static/css/5dcc38b90034d324.css" as="style"/><link rel="stylesheet" href="/_next/static/css/5dcc38b90034d324.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script defer="" src="https://fonts.googleapis.com/css?family=Open+Sans&amp;display=swap" data-nscript="beforeInteractive"></script><script src="/_next/static/chunks/webpack-b653c683a51d8b57.js" defer=""></script><script src="/_next/static/chunks/framework-73b8966a3c579ab0.js" defer=""></script><script src="/_next/static/chunks/main-34cb81d5753e1fc4.js" defer=""></script><script src="/_next/static/chunks/pages/_app-9cc101b503fd5646.js" defer=""></script><script src="/_next/static/chunks/655-d6e1933688b2da2a.js" defer=""></script><script src="/_next/static/chunks/pages/domains/%5Bdomain%5D/categories/%5Bslug%5D-06ee3613a207102c.js" defer=""></script><script src="/_next/static/1bBCYhXOG7wsYuaBifvjK/_buildManifest.js" defer=""></script><script src="/_next/static/1bBCYhXOG7wsYuaBifvjK/_ssgManifest.js" defer=""></script><style data-styled="" data-styled-version="5.3.9"></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Trade+Gothic+Lt+Bold%7COpen+Sans%7CTrade+Gothic+Lt&display=swap"/></head><body><div id="__next"><div class="Layout_container__gktH6"><div class="Layout_navbar-container__gCfDZ" style="height:64px"><nav class="_wrapper_jbnbd_1"><div class="_container_jbnbd_15"><a class="_navbar-brand_jbnbd_29" aria-label="Pharmafocus" href="/"><div class="_navbar-image_jbnbd_40"><img alt="Logo" loading="lazy" decoding="async" data-nimg="fill" class="_image_jbnbd_43" style="position:absolute;height:100%;width:100%;left:0;top:0;right:0;bottom:0;color:transparent" sizes="100vw" srcSet="https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 54w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 70w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 82w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 96w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 110w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 128w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 138w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 192w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 200w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 252w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 260w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 298w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 378w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 384w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 520w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 640w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 756w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 828w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1080w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1200w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 1920w, https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png 2048w" src="https://media.magloft.app/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png"/></div><div class="_navbar-title_jbnbd_58 _navbar-title-hide_jbnbd_101"></div></a><div id="navbar-children-container" class="_navbar-children_jbnbd_116"><div class="_menu_1jhrl_1"><div class="_menu-wrapper_1jhrl_22"><div class="_menu-items_1jhrl_38"><a class="_menu-item_1jhrl_38" href="/"><div class="_menu-home_1lm7t_255 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Home</div><div class="_indicator_1jhrl_63"></div></a><a class="_menu-item_1jhrl_38" href="/articles"><div class="_menu-articles_1lm7t_259 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Articles</div><div class="_indicator_1jhrl_63"></div></a><a class="_menu-item_1jhrl_38 _active_1jhrl_70" href="/collections"><div class="_menu-issues_1lm7t_263 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Magazines</div><div class="_indicator_1jhrl_63 _active_1jhrl_70"></div></a><a class="_menu-item_1jhrl_38" href="/account/login"><div class="_menu-account_1lm7t_411 _menu-item-icon_1jhrl_97 _icon_1lm7t_1 icon"></div><div class="_menu-item-title_1jhrl_88">Log in</div><div class="_indicator_1jhrl_63"></div></a></div></div></div></div><div id="navbar-suffix" class="_navbar-suffix_jbnbd_108"><div class="Layout_menu-actions__vsDbI"><div class="Layout_install-button__FBfSr"><div class="Tooltip_tooltip__98Sw9"></div><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button" style="color:var(--top-menu-item-icon-color, var(--background-color))" role="button" aria-label="Search" aria-labelledby="labeldiv" title="Search"><div class="_action-search_1lm7t_15 _icon-button_19h3g_19 _icon_1lm7t_1 icon" style="background-color:var(--top-menu-item-icon-color, var(--background-color))"></div></button></div></div></div></div></nav></div><div class="Layout_main__evUHx"><div class="Layout_spacer__qTBD3" style="height:64px"></div><div class="_slug__wrapper__ruU0S"><div class="_slug__category-header__7cydo"><img alt="Issue Cover" loading="lazy" width="128" height="128" decoding="async" data-nimg="1" class="_slug__category-image___YpSr" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 128 128&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" srcSet="https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=128&amp;aspectRatio=1 1x, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1 2x" src="https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;width=256&amp;aspectRatio=1"/><h2>UK News</h2><p>The latest from the UK pharmacuetical industry</p></div><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#444444">Collections</h2></div></div><div class="IssueList_wrapper__cNptl"><div class="infinite-scroll-component__outerdiv"><div class="infinite-scroll-component " style="height:auto;overflow:visible;-webkit-overflow-scrolling:touch"><div class="IssueList_container__tG81k"><div class="_card_1s1n3_1 card raised interactive"><div class="_card-body_1s1n3_12 card-body"><div class="_issue-cover_1s1n3_17"><a href="/collections/pharmafocus-november-2024"><img alt="issue-item" loading="lazy" width="768" height="1024" decoding="async" data-nimg="1" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 768 1024&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 796px) 200px, (min-width: 601px) 252px, 192px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></a></div><div class="_issue-detail_1s1n3_27"><div class="_issue-detail-header_1s1n3_33"><div class="_card-date_1s1n3_39"><a href="/collections/pharmafocus-november-2024"><span>UK News<!-- -->聽</span>15 November 2024</a></div></div><div class="_issue-detail-content_1s1n3_52"><div><a href="/collections/pharmafocus-november-2024"><p class="_card-title_1s1n3_56">Pharmafocus November 2024</p><p class="_description_1s1n3_67">Welcome to Pharmafocus November 2024!</p></a></div></div><div class="_issue-action-wrapper_1s1n3_79"><a href="/collections/pharmafocus-november-2024"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _primary_19h3g_15" type="button" role="button" aria-label="Pending" aria-labelledby="labeldiv">...</button></a></div></div></div></div><div class="_card_1s1n3_1 card raised interactive"><div class="_card-body_1s1n3_12 card-body"><div class="_issue-cover_1s1n3_17"><a href="/collections/pharmafocus-october-2024"><img alt="issue-item" loading="lazy" width="768" height="1024" decoding="async" data-nimg="1" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 768 1024&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 796px) 200px, (min-width: 601px) 252px, 192px" srcSet="https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></a></div><div class="_issue-detail_1s1n3_27"><div class="_issue-detail-header_1s1n3_33"><div class="_card-date_1s1n3_39"><a href="/collections/pharmafocus-october-2024"><span>UK News<!-- -->聽</span>10 October 2024</a></div></div><div class="_issue-detail-content_1s1n3_52"><div><a href="/collections/pharmafocus-october-2024"><p class="_card-title_1s1n3_56">Pharmafocus October 2024</p><p class="_description_1s1n3_67">Welcome to the October 2024 edition of Pharmafocus!</p></a></div></div><div class="_issue-action-wrapper_1s1n3_79"><a href="/collections/pharmafocus-october-2024"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _primary_19h3g_15" type="button" role="button" aria-label="Pending" aria-labelledby="labeldiv">...</button></a></div></div></div></div><div class="_card_1s1n3_1 card raised interactive"><div class="_card-body_1s1n3_12 card-body"><div class="_issue-cover_1s1n3_17"><a href="/collections/pharmafocus-september-2024"><img alt="issue-item" loading="lazy" width="768" height="1024" decoding="async" data-nimg="1" style="color:transparent;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 768 1024&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 796px) 200px, (min-width: 601px) 252px, 192px" srcSet="https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=16 16w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=32 32w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=48 48w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=54 54w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=64 64w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=70 70w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=82 82w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=96 96w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=110 110w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=128 128w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=138 138w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=192 192w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=200 200w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=252 252w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=256 256w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=260 260w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=298 298w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=378 378w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=384 384w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=520 520w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=640 640w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=756 756w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=828 828w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1080 1080w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1200 1200w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=1920 1920w, https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048 2048w" src="https://media.magloft.app/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png?optimizer=image&amp;format=webp&amp;aspectRatio=0.75&amp;width=2048"/></a></div><div class="_issue-detail_1s1n3_27"><div class="_issue-detail-header_1s1n3_33"><div class="_card-date_1s1n3_39"><a href="/collections/pharmafocus-september-2024"><span>UK News<!-- -->聽</span>5 September 2024</a></div></div><div class="_issue-detail-content_1s1n3_52"><div><a href="/collections/pharmafocus-september-2024"><p class="_card-title_1s1n3_56">Pharmafocus September 2024</p><p class="_description_1s1n3_67">Welcome to the September 2024 issue of Pharmafocus! This issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck鈥檚 KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year&#x27;s CPHI in Milan! </p></a></div></div><div class="_issue-action-wrapper_1s1n3_79"><a href="/collections/pharmafocus-september-2024"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _primary_19h3g_15" type="button" role="button" aria-label="Pending" aria-labelledby="labeldiv">...</button></a></div></div></div></div></div></div></div></div><div style="height:auto" class="BlockHeader_block-header__JmokO"><div class="BlockHeader_container-title__l5lHB"><h2 style="border-bottom-color:#444444">Articles</h2></div></div><div class="ArticleList_wrapper__T0ntw"><div class="infinite-scroll-component__outerdiv"><div class="infinite-scroll-component " style="height:auto;overflow:visible;-webkit-overflow-scrolling:touch"><div class="ArticleList_container__ln6vK"><a class="_card_n1ew6_1" href="/articles/clue-points-launches-medical-safety-review-msr-software-for-c"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">CluePoints launches Medical &amp; Safety Review (MSR) software</span><p class="">Risk-based quality management (RBQM) and data quality oversight software company Cluepoints launches its latest application, the medical &amp; safety review (MSR), to simplify and streamline the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the data history.</p><div class="_card-date_n1ew6_142">10 October 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/next-generation-sequencing-partnership-announced-between-angle-p"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_10-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Next-generation sequencing partnership announced between ANGLE plc and NuProbe</span><p class="">Liquid biopsy company ANGLE plc has announced a partnership with NuProbe, a genomics and molecular diagnostics company, to utilise the latter鈥檚 pan-cancer next-generation sequencing (NGS) panel.</p><div class="_card-date_n1ew6_142">10 October 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">R &amp; D</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/fda-approves-first-drug-in-50-years-for-treatment-of-schizophren"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">FDA approves first drug in 50 years for treatment of schizophrenia in adults</span><p class="">Earlier this September, the US Food and Drug Administration (FDA) granted approval for PureTech Health鈥檚 Karxt for the treatment of schizophrenia in adults, triggering royalty payments of $29m to PureTech. It will be the first approved mechanism by the FDAfor schizophrenia in over 50 years.</p><div class="_card-date_n1ew6_142">9 October 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/research-collaboration-between-fda-and-owlstone-medical-set-to-s"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1125/images/img_2-3.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Research collaboration between FDA and Owlstone Medical set to see improvements in breath biopsies</span><p class="">Owlstone Medical has entered into a research collaboration with the US Food and Drug administration鈥檚 (FDA) centre for devices and radiological health to develop methods for the confident identification of individual chemicals in the composure of breath.</p><div class="_card-date_n1ew6_142">9 October 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_1-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">First nasal spray for treatment of anaphylaxis approved by FDA</span><p class="">Ars pharmaceuticals has been granted approval by the us food and drug administration (fda) for their epinephrine nasal spray, neffy, to be used as treatment of type 1 allergic reactions including anaphylaxis.</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">General News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/novo-holdings-invests-in-oxford-nanopore-technologies"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_4-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Novo Holdings invests in Oxford Nanopore Technologies</span><p class="">Leading life science investor novo holdings has announced a 拢50m investment in oxford nanopore technologies. Oxford nanopore technologies is a leading uk-listed company currently specialising in a new generation of molecular sensing technology based on nanopores.</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/cresset-collaborates-with-enamine-to-enable-the-design-of-new-ta"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_4-2.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Cresset collaborates with Enamine to enable the design of new targeted protein degraders</span><p class="">Drug discovery company Cresset has announced the extension of its global collaboration with chemical and biological contract research organisation (cro) Enamine.</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/first-oral-treatment-for-hormone-sensitive-prostate-cancer-recom"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/pages/pg-005.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">First oral treatment for hormone-sensitive prostate cancer recommended by NICE</span><p class="">Accord healthcare have recently announced that NICE have recommended the first oral androgen deprivation therapy (adt) treatment for hormone-sensitive prostate cancer. Prostate cancer is the most common cancer in men across the uk.</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/verisense-announce-opening-of-digital-biobank"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_5-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Verisense announce opening of Digital Biobank</span><p class="">This month, Verisense have announced that their digital biobank, with data from over one million people, is open for business.</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/positive-results-announced-for-levicept-s-moderate-to-severe-ost"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_6-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Positive results announced for Levicept鈥檚 moderate-to-severe osteoarthritis treatment</span><p class="">Biotechnology company Levicept has announced positive results from its phase 2 trial into levi-04 for the treatment of osteoarthritis.</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/calliditas-therapeutics-announces-positive-phase-2b-data-in-prim"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/pages/pg-007.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">Calliditas Therapeutics announces positive phase 2b data in Primary Biliary Cholangitis trial</span><p class="">Calliditas therapeutics ab has recently announced that the phase 2b transform trial met its primary endpoint. The trial showed statistically significant improvement in alkaline phosphatase (alp) for both doses tested versus placebo.聽the trial evaluated setanaxib, a nox enzyme inhibitor, in patients with primary biliary cholangitis (pbc) and elevated liver stiffness.</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a><a class="_card_n1ew6_1" href="/articles/chmp-gives-positive-opinion-for-merck-s-keytruda-for-unresectabl"><div class="_card-header_n1ew6_50"><img alt="article-item" loading="lazy" width="86" height="64.5" decoding="async" data-nimg="1" style="color:transparent;width:100%;height:auto;background-size:cover;background-position:50% 50%;background-repeat:no-repeat;background-image:url(&quot;data:image/svg+xml;charset=utf-8,%3Csvg xmlns=&#x27;http%3A//www.w3.org/2000/svg&#x27; viewBox=&#x27;0 0 86 64.5&#x27;%3E%3Cfilter id=&#x27;b&#x27; color-interpolation-filters=&#x27;sRGB&#x27;%3E%3CfeGaussianBlur stdDeviation=&#x27;20&#x27;/%3E%3C/filter%3E%3Cimage preserveAspectRatio=&#x27;none&#x27; filter=&#x27;url(%23b)&#x27; x=&#x27;0&#x27; y=&#x27;0&#x27; height=&#x27;100%25&#x27; width=&#x27;100%25&#x27; href=&#x27;data:image/gif;base64,R0lGODlhAQABAPAAANzc3P///yH5BAAAAAAALAAAAAABAAEAAAICRAEAOw==&#x27;/%3E%3C/svg%3E&quot;)" sizes="(min-width: 874px) 38vw, (min-width: 720px) 44vw, (min-width: 601px) 19vw, 10vw" srcSet="https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=16 16w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=32 32w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=48 48w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=54 54w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=64 64w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=70 70w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=82 82w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=96 96w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=110 110w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=128 128w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=138 138w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=192 192w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=200 200w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=252 252w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=256 256w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=260 260w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=298 298w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=378 378w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=384 384w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=520 520w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=640 640w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=756 756w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=828 828w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1080 1080w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1200 1200w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=1920 1920w, https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048 2048w" src="https://media.magloft.app/pdf-import/1110/images/img_7-1.jpg?optimizer=image&amp;format=webp&amp;aspectRatio=1.33&amp;width=2048"/></div><div class="_card-body_n1ew6_86"><span class="_card-title_n1ew6_103">CHMP gives positive opinion for Merck鈥檚 KEYTRUDA for unresectable or metastatic urothelial carcinoma</span><p class="">Merck (known as MSDoutside of the US and Canada) has announced that its anti-pd-1 therapy, in combination with padcev (enfortuman vedotin-ejfv), has received a positive opinion from the European Medicines Agency (EMA)</p><div class="_card-date_n1ew6_142">5 September 2024<span class="_category-chip_n1ew6_155" style="background-color:#444444">UK News</span></div></div><div class="_card-footer_n1ew6_162"><button class="_button_19h3g_1 _text_19h3g_12 _medium_19h3g_38 _secondary_19h3g_22" type="button">Read More</button></div></a></div></div></div></div></div></div><script> //create a new element const terms = document.createElement('div'); //set id terms.setAttribute("id","billboard-banner"); //add the new element to html var body = document.querySelector('body'); body.appendChild(terms); document.querySelector("#billboard-banner").innerHTML = "<ins data-revive-zoneid='1573' data-revive-id='9c421b7e485bf2edfee09708a4d06e2e'></ins>"; //insert new element before header //document.body.insertAdjacentElement('afterbegin', terms); const insElement = document.querySelector("#__next"); insElement.before(terms); </script> <script async="" src="//ads.datateam.co.uk/www/delivery/asyncjs.php"></script><div class="_footer_j8nu5_1"><div class="_container_j8nu5_12"><div class="_footer-row_j8nu5_23"><div class="_footer-column_j8nu5_36 _flex-2_j8nu5_117"><div class="_footer-brand_j8nu5_43"><div class=""><img alt="Logo" loading="lazy" width="40" height="40" decoding="async" data-nimg="1" class="_footer-logo_j8nu5_57" style="color:transparent" srcSet="https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png 1x, https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png 2x" src="https://media.magloft.app/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png"/></div><div class="_content_j8nu5_67"><h3>Pharmafocus</h3><p>Pharmaceutical Industry news, analysis and insights</p></div></div><div class="_footer-link-list_j8nu5_121"><div class="_block_j8nu5_129"><a class="_footer-link-item_j8nu5_92" rel="noreferrer" href="mailto:info@pharmafile.com"><div class="_form-email_1lm7t_143 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>info@pharmafile.com</span></a></div><div class="_block_j8nu5_129"><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="http://www.pharmafile.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Pharmafile.com</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://magazine.pharmafile.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Pharmafile Magazine</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="http://www.samedanltd.com"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Samedan</span></a></div><a target="_blank" rel="noreferrer" class="_footer-link-item_j8nu5_92" href="https://www.pharmafile.com/privacy-policy"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Privacy Policy</span></a><a target="_blank" rel="noreferrer" class="_footer-link-item_j8nu5_92" href="https://www.pharmafile.com/terms-of-service"><div class="_status-info_1lm7t_87 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span>Terms of Service</span></a></div></div><div class="_footer-column_j8nu5_36 _flex-1_j8nu5_39"><div class="_footer-brand_j8nu5_43"><div class="_status-accent_1lm7t_91 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><div class="_content_j8nu5_67"><h3>Categories</h3><p>Explore our inspiring content by topic</p></div></div><div class="_footer-link-list_j8nu5_121"><a class="_footer-link-item_j8nu5_92" href="/categories/uk-pharma-news"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>UK News</a><a class="_footer-link-item_j8nu5_92" href="/categories/general-news"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>General News</a><a class="_footer-link-item_j8nu5_92" href="/categories/approvals"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Approvals</a><a class="_footer-link-item_j8nu5_92" href="/categories/research-and-development"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>R &amp; D</a><a class="_footer-link-item_j8nu5_92" href="/categories/mergers-acquisitions"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Mergers &amp; Acquisitions</a><a class="_footer-link-item_j8nu5_92" href="/categories/manufacturing-production"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Manufacturing</a><a class="_footer-link-item_j8nu5_92" href="/categories/clinical-trials"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Clinical Trials</a><a class="_footer-link-item_j8nu5_92" href="/categories/industry-insights"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Industry Insights</a><a class="_footer-link-item_j8nu5_92" href="/categories/appointments"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Appointments</a><a class="_footer-link-item_j8nu5_92" href="/categories/insider-interviews"><div class="_nav-arrow-right_1lm7t_175 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div>Interviews</a></div></div><div class="_footer-column_j8nu5_36 _flex-1_j8nu5_39"><div class="_footer-brand_j8nu5_43"><div class="_share-action_1lm7t_463 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><div class="_content_j8nu5_67"><h3>Social Footprints</h3><p>Follow us on our Social Media Channels</p></div></div><div class="_footer-link-list_j8nu5_121"><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://twitter.com/Pharmafocus"><div class="_share-twitter_1lm7t_487 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span class="_footer-text_j8nu5_125">X</span></a><a class="_footer-link-item_j8nu5_92" target="_blank" rel="noreferrer" href="https://www.linkedin.com/company/pharmafile"><div class="_share-linkedin_1lm7t_483 _footer-icon_j8nu5_58 _icon_1lm7t_1 icon"></div><span class="_footer-text_j8nu5_125">linkedin</span></a></div></div></div></div></div></div><div class="Toastify"></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"domain":"www.pharmafocus.com","pwa":{"id":664,"publicationId":14882,"pwaOptinId":656,"domain":"www.pharmafocus.com","config":{"access":{"concurrentLimit":null,"restrictAnonymous":null,"disableSignup":null,"disableLogin":null,"disableLoginMessage":null,"disableSearchIndexing":false,"signupUrl":null,"resetPasswordUrl":null,"isUsernameLogin":null,"disableEditProfile":null,"formUrl":null,"customMarginResetPassword":null},"push":{"google":{"serverPublicKey":"BGfKWie38SRvrZs4-bDa1N70rhULMBqX8nAvBZT_2OXsMQi3uRA0CaK4JKPuib9Ega28liCTGhBx0QCY4t1QU7o"}},"tracking":{"facebook":{"appId":null,"pixelId":null},"google":{"measurementId":"G-D8QLP3CKWG"},"gtm":null,"sentry":true},"payment":{"stripe":null,"bypassPayment":null,"mode":"none","external":null,"currency":null},"email":{"readerOptin":false},"firebase":{"projectId":"ipt-magloft","senderId":"497261264876","pairKey":null,"webAppConfig":{"apiKey":"AIzaSyBcHBC8k394YdXp19dZj2Xqe8CXCgThBZs","appId":"1:497261264876:web:98452398b320341bd68ac9","authDomain":"ipt-magloft.firebaseapp.com","databaseURL":null,"locationId":null,"messagingSenderId":"497261264876","projectId":"ipt-magloft","storageBucket":"ipt-magloft.appspot.com"}},"customHtml":{"head":"\u003cscript type=\"text/javascript\" src=\"https://cdn.jsdelivr.net/npm/cookie-bar/cookiebar-latest.min.js?customize=1\u0026always=1\u0026showNoConsent=1\" onload=\"setupCookieBar();\"\u003e\u003c/script\u003e\n\u003cmeta name=\"google-site-verification\" content=\"kuOvGxaH_NjG3aS7GSmbjjV-OjdOAWyiM3gEPGESeHQ\" /\u003e\n\u003cstyle\u003e\n#billboard-banner { text-align:center;}\n#billboard-banner img {width:100%; max-width:970px; height:auto; position:relative; top:70px;}\n.Layout_spacer__qTBD3 {margin-top:70px;}\n\u003c/style\u003e","body":"\u003cscript\u003e\n //create a new element\n const terms = document.createElement('div');\n //set id\n terms.setAttribute(\"id\",\"billboard-banner\");\n //add the new element to html\n var body = document.querySelector('body');\n body.appendChild(terms);\n document.querySelector(\"#billboard-banner\").innerHTML = \"\u003cins data-revive-zoneid='1573' data-revive-id='9c421b7e485bf2edfee09708a4d06e2e'\u003e\u003c/ins\u003e\"; \n //insert new element before header\n//document.body.insertAdjacentElement('afterbegin', terms);\n const insElement = document.querySelector(\"#__next\");\n insElement.before(terms);\n\u003c/script\u003e\n\u003cscript async src=\"//ads.datateam.co.uk/www/delivery/asyncjs.php\"\u003e\u003c/script\u003e"},"account":{"emailEditable":true,"customSubscriptionText":null,"customSubscriptionURL":null,"enableSubscriptionTitle":null},"checkout":null},"design":{"colors":{"backgroundColor":"#FFFFFF","primaryColor":"#1976D2","secondaryColor":"#795FF4","accentColor":"#D76FD6","infoColor":"#41638C","warningColor":"#EF9338","successColor":"#20AD27","dangerColor":"#DF4241","topMenuBackgroundColor":"#EE1C25","topMenuHeadingTitleColor":null,"topMenuHeadingIconColor":null,"topMenuItemTextColor":null,"topMenuItemIconColor":null,"footerMenuBackgroundColor":"#DF1111","footerMenuHeadingTitleColor":null,"footerMenuHeadingTextColor":null,"footerMenuHeadingIconColor":null,"footerMenuItemTextColor":null,"footerMenuItemIconColor":null},"images":{"icon":"https://cdn.magloft.com/pwa-664/pwa/logo/8eb186e1-b2cb-4384-a0b7-515f62171b22.png","feature":"https://cdn.magloft.com/defaults/feature-graphic.jpg","topMenuIcon":"https://cdn.magloft.com/pwa-664/pwa/top-menu-icon/c215ba48-44be-411d-8753-7438a6acf8fb.png","footerMenuIcon":null,"alphaChannelIcon":null},"fonts":{"heading":"trade-gothic-lt-bold","body":"open-sans","ui":"trade-gothic-lt-bold","topMenuTitle":"trade-gothic-lt-bold","topMenuItems":"trade-gothic-lt","topMenuSubtitle":"trade-gothic-lt","footerMenuTitle":null,"footerMenuItems":null},"menuItems":{"collections":{"title":"Magazines"},"articles":{"title":null},"account":{"title":null},"icons":{"enabled":true}},"footerShape":"flat","issueCoverAspectRatio":0.75,"fullscreenCollectionView":"auto","customOverlayToggleView":false,"defaultViewMode":"html","categories":"flat","purchaseList":true,"libraryList":false,"noteList":false,"textToSpeech":false},"layout":{"banners":[{"image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","title":"Start trial now","isHidden":true,"action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"bottomBanners":[{"image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","title":null,"isHidden":true,"action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}],"columnSeparator":"shadow","tabs":[{"route":"","title":"Home","icon":"menu-home","visible":true},{"route":"/articles","title":"Articles","icon":"menu-articles","visible":true},{"route":"/collections","title":"Collections","icon":"menu-issues","visible":true},{"route":"/account","title":"Account","icon":"menu-account","visible":true}],"topMenu":{"showLogo":true,"showSubtitle":false,"showTitle":false,"height":"64px"},"navbar":{"animation":false,"style":"logo-left"},"sections":[{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-1/pwa/banner/aea74608-e04a-4649-b817-c45cc439e28e.png","isHidden":true,"title":"Start trial now","action":{"type":"url","href":"https://www.magloft.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]},{"fullWidth":false,"backgroundColor":null,"columnSeparator":"shadow","columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},{"fullWidth":true,"backgroundColor":"transparent","columnSeparator":"none","columns":[{"size":5,"blocks":[{"type":"banner","image":"https://cdn.magloft.com/pwa-664/pwa/banner/1f66e6ea-9b3a-4477-aba1-18abf54619b8.png","isHidden":true,"title":"","action":{"type":"url","href":"http://www.samedanltd.com/","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}}]}]}],"columns":[{"size":8.5,"blocks":[{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":892,"condition":null},{"type":"article-list","condition":null,"color":"#F90505","title":"Top Content","variant":"variant-b","articleIds":[262748,254614,260494,260493,260492,258749],"articles":null},{"type":"article-list","condition":null,"color":"#2873B0","title":"Industry Insights","variant":"variant-b","articleIds":[260492,260493,260494,258746,258745,257361],"articles":null},{"type":"article-category","condition":null,"color":"#F90505","title":"UK News","variant":"variant-c","categoryId":43138,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"Global News","variant":"variant-c","categoryId":43140,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[1319],"adCampaignId":null,"condition":null},{"type":"article-category","condition":null,"color":"#2873B0","title":"European News","variant":"variant-c","categoryId":43139,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"guide-install","color":"#444558","title":"How to Install","condition":null}]},{"size":3.5,"blocks":[{"type":"issue-slider","condition":null,"color":"#2873B0","title":"Latest Editions","issueIds":[52826,52799,52483,52217,51921,51722,51533,51435,51240,51075,45938,45939,45940],"thumbnail":{"style":"full-cover","size":"medium"},"borderRadius":null,"zoomOnHover":true,"issues":null},{"type":"ad","title":"Advertisement","advertisementIds":[2210],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-gift","color":"#FB0505","title":"Newsletters","description":"Sign up to our newsletters and digital magazines","action":{"type":"url","href":"https://curwoodcmsltd.formstack.com/forms/samedan","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[2067],"adCampaignId":null,"condition":null},{"type":"cta","condition":null,"icon":"symbol-day","color":"#F90505","title":"Pharmafocus Archive","description":"Browse older editions","action":{"type":"url","href":"https://en.calameo.com/subscriptions/6188508","target":"_blank","pwaSubscriptionId":null,"pwaSubscription":null,"optinId":null,"optin":null}},{"type":"ad","title":"Advertisement","advertisementIds":[],"adCampaignId":1044,"condition":null},{"type":"article-category","condition":null,"color":"#F70707","title":"Appointments","variant":"variant-c","categoryId":43146,"backgroundColor":null,"image":null,"articles":null,"category":null},{"type":"ad","title":"Advertisement","advertisementIds":[2249,1320],"adCampaignId":null,"condition":null}]}]},"seo":{"home":{"title":"Pharmafocus Magazine - covering pharma and biotech since 1986","description":"Reporting on the pharma industry, drug development \u0026 clinical trials, manufacturing, logistics, market access, and patients.\nFrom breaking stories to interviews with senior executives, we look at regulations \u0026 trends to provide useful market intelligence.","image":"https://cdn.magloft.com/pwa-664/seo/image/270800d8-b1de-41b8-86ad-5d262d2b9adf.png","imageAlt":"Pharmafocus Magazine"},"articles":{"title":"Pharmafocus - Articles","description":"Discover the latest articles published by Pharmafocus. Browse and customize the article feed to your preferences and explore latest trends","image":"https://cdn.magloft.com/pwa-664/seo/image/e7a95017-d617-4914-b4b3-09fcfc683f75.png","imageAlt":"Pharmafocus - Articles"},"issues":{"title":"Pharmafocus - Magazine Issues","description":"Explore the latest issues of Pharmafocus Magazine and keep up to date with the latest industry knowledge","image":"https://cdn.magloft.com/pwa-664/seo/image/b1c374f3-b368-4654-bf00-3b5ed81fe6c2.png","imageAlt":"Pharmafocus - Issues"},"account":{"title":"Pharmafocus - Account","description":"Manage your Pharmafocus Reader Account..","image":"https://cdn.magloft.com/pwa-664/seo/image/5ad881b1-a927-4fb1-b331-81963e9a0f84.png","imageAlt":"Reader Account"}},"strings":{"app":{"title":"Pharmafocus","subtitle":"Pharmaceutical Industry news, analysis and insights"},"social":{"facebook":null,"twitter":"https://twitter.com/Pharmafocus","linkedin":"https://www.linkedin.com/company/pharmafile","youtube":null,"instagram":null},"topMenu":{"title":null,"subtitle":null},"footerMenu":{"title":"Pharmafocus","subtitle":null,"description":null,"email":["info@pharmafile.com"],"privacyUrl":"https://www.pharmafile.com/privacy-policy","termsUrl":"https://www.pharmafile.com/terms-of-service","links":[{"name":"Pharmafile.com","url":"http://www.pharmafile.com"},{"name":"Pharmafile Magazine","url":"https://magazine.pharmafile.com"},{"name":"Samedan","url":"http://www.samedanltd.com"}]},"pages":null},"customFonts":[{"identifier":"trade-gothic-lt"},{"identifier":"trade-gothic-lt-bold"}],"phrases":{},"trialEndAt":null,"bypassSubscription":false},"publication":{"id":14882,"title":"Pharmafocus","properties":{"subtitle":null,"appIcon":"images/defaults/app-icon.png","promotionalText":null,"companyName":null,"emailReplyTo":"","privacyUrl":null,"termsUrl":null}},"categories":[{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":3,"articleCount":79,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":3,"articleCount":78,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":3,"articleCount":159,"categoryGroupIds":[]},{"id":43141,"slug":"research-and-development","title":"R \u0026 D","color":"#444444","issueCount":1,"articleCount":174,"categoryGroupIds":[]},{"id":43143,"slug":"mergers-acquisitions","title":"Mergers \u0026 Acquisitions","color":"#444444","issueCount":0,"articleCount":69,"categoryGroupIds":[]},{"id":43144,"slug":"manufacturing-production","title":"Manufacturing","color":"#444444","issueCount":1,"articleCount":31,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":2,"articleCount":33,"categoryGroupIds":[]},{"id":43145,"slug":"industry-insights","title":"Industry Insights","color":"#444444","issueCount":1,"articleCount":56,"categoryGroupIds":[]},{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":2,"articleCount":87,"categoryGroupIds":[]},{"id":43147,"slug":"insider-interviews","title":"Interviews","color":"#444444","issueCount":0,"articleCount":9,"categoryGroupIds":[]},{"id":43148,"slug":"features","title":"Features","color":"#444444","issueCount":0,"articleCount":20,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":2,"articleCount":23,"categoryGroupIds":[]}],"pwaSubscriptions":[],"categoryGroups":[],"category":{"id":43138,"slug":"uk-pharma-news","title":"UK News","description":"The latest from the UK pharmacuetical industry","color":"#444444","icon":"symbol-bell","image":"https://cdn.magloft.com/pdf-import/1125/images/img_6-1.jpg","position":1,"seoDescription":"Pharmafocus brings you the latest from the UK pharmacuetical industry","categoryGroupIds":[]},"issues":[{"id":52826,"slug":"pharmafocus-november-2024","unlockType":"free","entryArticleSlug":"survey-from-roche-finds-worryingly-low-understandings-about-hpv-a2ec","priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus November 2024","description":"Welcome to Pharmafocus November 2024!","date":1731628800000,"updatedAt":1731925217000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/2db03f67-b154-4bb4-8f8a-9fd8660f932b.jpg","source":"typeloft2","aspectRatio":0.706,"categoryIds":[43138,43139,43140,43141,43146,43144,43142],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":"pwa-664/pdf-import/pdf/2db03f67-b154-4bb4-8f8a-9fd8660f932b.pdf","keywordPhrase":null,"seoDescription":null,"categories":[{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43144,"slug":"manufacturing-production","title":"Manufacturing","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43141,"slug":"research-and-development","title":"R \u0026 D","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":false,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[]},{"id":52483,"slug":"pharmafocus-october-2024","unlockType":"free","entryArticleSlug":"fda-approves-first-drug-in-50-years-for-treatment-of-schizophren","priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus October 2024","description":"Welcome to the October 2024 edition of Pharmafocus!","date":1728601200000,"updatedAt":1731675001000,"coverUrl":"https://cdn.magloft.com/pwa-664/pdf-import/cover/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.jpg","source":"typeloft2","aspectRatio":0.706,"categoryIds":[43138,43139,43140,43149,43145,43146,43142],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":"pwa-664/pdf-import/pdf/c2153c79-00ca-4630-a0f2-5b8f0b47a8cc.pdf","keywordPhrase":null,"seoDescription":null,"categories":[{"id":43146,"slug":"appointments","title":"Appointments","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43142,"slug":"industry-facts","title":"Industry Facts","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43145,"slug":"industry-insights","title":"Industry Insights","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":true,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[]},{"id":52217,"slug":"pharmafocus-september-2024","unlockType":"free","entryArticleSlug":"first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda","priceTier":null,"hasPdf":false,"publicationId":14882,"title":"Pharmafocus September 2024","description":"Welcome to the September 2024 issue of Pharmafocus! \nThis issue covers the latest news including new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on Merck鈥檚 KEYTRUDA, as well as articles on precision medicine and oral peptides PLUS what to look out for at this year's CPHI in Milan! ","date":1725577200000,"updatedAt":1725970662000,"coverUrl":"https://cdn.magloft.com/pwa-664/issue/cover/8c56ddb8-0110-48f9-9380-d5f8d77b55b7.png","source":"typeloft2","aspectRatio":0.706,"categoryIds":[43138,43139,43140,43149],"pwaOptinId":null,"pwaSubscriptionIds":[],"classificationIds":[],"sourceFile":"pwa-664/pdf-import/pdf/7c2665b2-7a4f-486f-ae94-622756ac873a.pdf","keywordPhrase":null,"seoDescription":"September 2024 issue of Pharmafocus! \nIncluding new FDA approval for primary biliary cholangitis, NICE recommendations for skyrizi (risankizumab), CHMP opinion on KEYTRUDA, articles on precision medicine \u0026 oral peptides PLUS a guide to CPHI in Milan! ","categories":[{"id":43140,"slug":"approvals","title":"Approvals","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43149,"slug":"clinical-trials","title":"Clinical Trials","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43139,"slug":"general-news","title":"General News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]},{"id":43138,"slug":"uk-pharma-news","title":"UK News","color":"#444444","issueCount":0,"articleCount":0,"categoryGroupIds":[]}],"properties":{"allowPdfDownload":true,"allowRead":true,"pdfOnly":false,"checkoutUrl":null},"screenshots":[]}],"articles":[{"id":266508,"slug":"clue-points-launches-medical-safety-review-msr-software-for-c","issueId":52483,"categoryIds":[43138,43139],"title":"CluePoints launches Medical \u0026 Safety Review (MSR) software","description":"Risk-based quality management (RBQM) and data quality oversight software company Cluepoints launches its latest application, the medical \u0026 safety review (MSR), to simplify and streamline the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the data history.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_6-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266508.jpg?ts=1728470493","date":1728601200000,"unlockType":"free","categories":[{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"sMgX71Spwg8I","visible":true,"showOnToc":true,"bookmark":false,"position":11},{"id":266516,"slug":"next-generation-sequencing-partnership-announced-between-angle-p","issueId":52483,"categoryIds":[43141,43138],"title":"Next-generation sequencing partnership announced between ANGLE plc and NuProbe","description":"Liquid biopsy company ANGLE plc has announced a partnership with NuProbe, a genomics and molecular diagnostics company, to utilise the latter鈥檚 pan-cancer next-generation sequencing (NGS) panel.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_10-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266516.jpg?ts=1728498303","date":1728601200000,"unlockType":"free","categories":[{"id":43141,"title":"R \u0026 D","slug":"research-and-development"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"AnOofZZMVHNB","visible":true,"showOnToc":true,"bookmark":false,"position":20},{"id":266499,"slug":"fda-approves-first-drug-in-50-years-for-treatment-of-schizophren","issueId":52483,"categoryIds":[43138,43140],"title":"FDA approves first drug in 50 years for treatment of schizophrenia in adults","description":"Earlier this September, the US Food and Drug Administration (FDA) granted approval for PureTech Health鈥檚 Karxt for the treatment of schizophrenia in adults, triggering royalty payments of $29m to PureTech. It will be the first approved mechanism by the FDAfor schizophrenia in over 50 years.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_1-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266499.jpg?ts=1728559805","date":1728514800000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"nsfAv0wcfXO4","visible":true,"showOnToc":true,"bookmark":false,"position":1},{"id":266500,"slug":"research-collaboration-between-fda-and-owlstone-medical-set-to-s","issueId":52483,"categoryIds":[43138],"title":"Research collaboration between FDA and Owlstone Medical set to see improvements in breath biopsies","description":"Owlstone Medical has entered into a research collaboration with the US Food and Drug administration鈥檚 (FDA) centre for devices and radiological health to develop methods for the confident identification of individual chemicals in the composure of breath.","image":"https://cdn.magloft.com/pdf-import/1125/images/img_2-3.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/266500.jpg?ts=1728470011","date":1728514800000,"unlockType":"free","categories":[{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"VLG11AdYxoxq","visible":true,"showOnToc":true,"bookmark":false,"position":3},{"id":262719,"slug":"first-nasal-spray-for-treatment-of-anaphylaxis-approved-by-fda","issueId":52217,"categoryIds":[43139,43138,43140],"title":"First nasal spray for treatment of anaphylaxis approved by FDA","description":"Ars pharmaceuticals has been granted approval by the us food and drug administration (fda) for their epinephrine nasal spray, neffy, to be used as treatment of type 1 allergic reactions including anaphylaxis.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_1-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262719.jpg?ts=1725620538","date":1725577200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"},{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"diSKryTa9pr6","visible":true,"showOnToc":true,"bookmark":false,"position":1},{"id":262727,"slug":"novo-holdings-invests-in-oxford-nanopore-technologies","issueId":52217,"categoryIds":[43138],"title":"Novo Holdings invests in Oxford Nanopore Technologies","description":"Leading life science investor novo holdings has announced a 拢50m investment in oxford nanopore technologies. Oxford nanopore technologies is a leading uk-listed company currently specialising in a new generation of molecular sensing technology based on nanopores.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_4-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262727.jpg?ts=1725629148","date":1725577200000,"unlockType":"free","categories":[{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"dQRYLdeghvbj","visible":true,"showOnToc":true,"bookmark":false,"position":8},{"id":262728,"slug":"cresset-collaborates-with-enamine-to-enable-the-design-of-new-ta","issueId":52217,"categoryIds":[43138,43141],"title":"Cresset collaborates with Enamine to enable the design of new targeted protein degraders","description":"Drug discovery company Cresset has announced the extension of its global collaboration with chemical and biological contract research organisation (cro) Enamine.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_4-2.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262728.jpg?ts=1725629190","date":1725577200000,"unlockType":"free","categories":[{"id":43141,"title":"R \u0026 D","slug":"research-and-development"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"dQRYLdeghvbj","visible":true,"showOnToc":true,"bookmark":false,"position":9},{"id":262729,"slug":"first-oral-treatment-for-hormone-sensitive-prostate-cancer-recom","issueId":52217,"categoryIds":[43138,43139],"title":"First oral treatment for hormone-sensitive prostate cancer recommended by NICE","description":"Accord healthcare have recently announced that NICE have recommended the first oral androgen deprivation therapy (adt) treatment for hormone-sensitive prostate cancer. Prostate cancer is the most common cancer in men across the uk.","image":"https://cdn.magloft.com/pdf-import/1110/images/pages/pg-005.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262729.jpg?ts=1725629243","date":1725577200000,"unlockType":"free","categories":[{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"BkEyq2EaGSXX","visible":true,"showOnToc":true,"bookmark":false,"position":10},{"id":262730,"slug":"verisense-announce-opening-of-digital-biobank","issueId":52217,"categoryIds":[43138,43139,43149],"title":"Verisense announce opening of Digital Biobank","description":"This month, Verisense have announced that their digital biobank, with data from over one million people, is open for business.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_5-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262730.jpg?ts=1725629295","date":1725577200000,"unlockType":"free","categories":[{"id":43149,"title":"Clinical Trials","slug":"clinical-trials"},{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"BkEyq2EaGSXX","visible":true,"showOnToc":true,"bookmark":false,"position":11},{"id":262731,"slug":"positive-results-announced-for-levicept-s-moderate-to-severe-ost","issueId":52217,"categoryIds":[43138,43139],"title":"Positive results announced for Levicept鈥檚 moderate-to-severe osteoarthritis treatment","description":"Biotechnology company Levicept has announced positive results from its phase 2 trial into levi-04 for the treatment of osteoarthritis.","image":"https://cdn.magloft.com/pdf-import/1110/images/img_6-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262731.jpg?ts=1725617583","date":1725577200000,"unlockType":"free","categories":[{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"j2q1Pxi8l0SL","visible":true,"showOnToc":true,"bookmark":false,"position":12},{"id":262732,"slug":"calliditas-therapeutics-announces-positive-phase-2b-data-in-prim","issueId":52217,"categoryIds":[43138,43139],"title":"Calliditas Therapeutics announces positive phase 2b data in Primary Biliary Cholangitis trial","description":"Calliditas therapeutics ab has recently announced that the phase 2b transform trial met its primary endpoint. The trial showed statistically significant improvement in alkaline phosphatase (alp) for both doses tested versus placebo.聽the trial evaluated setanaxib, a nox enzyme inhibitor, in patients with primary biliary cholangitis (pbc) and elevated liver stiffness.","image":"https://cdn.magloft.com/pdf-import/1110/images/pages/pg-007.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262732.jpg?ts=1725630391","date":1725577200000,"unlockType":"free","categories":[{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"RtBjoShvBNoJ","visible":true,"showOnToc":true,"bookmark":false,"position":14},{"id":262733,"slug":"chmp-gives-positive-opinion-for-merck-s-keytruda-for-unresectabl","issueId":52217,"categoryIds":[43138,43139,43140],"title":"CHMP gives positive opinion for Merck鈥檚 KEYTRUDA for unresectable or metastatic urothelial carcinoma","description":"Merck (known as MSDoutside of the US and Canada) has announced that its anti-pd-1 therapy, in combination with padcev (enfortuman vedotin-ejfv), has received a positive opinion from the European Medicines Agency (EMA)","image":"https://cdn.magloft.com/pdf-import/1110/images/img_7-1.jpg","cover":"https://cdn.magloft.com/publication-14882/screenshots/articles/262733.jpg?ts=1725630477","date":1725577200000,"unlockType":"free","categories":[{"id":43140,"title":"Approvals","slug":"approvals"},{"id":43139,"title":"General News","slug":"general-news"},{"id":43138,"title":"UK News","slug":"uk-pharma-news"}],"pdfPageId":"RtBjoShvBNoJ","visible":true,"showOnToc":true,"bookmark":false,"position":15}]},"__N_SSG":true},"page":"/domains/[domain]/categories/[slug]","query":{"domain":"www.pharmafocus.com","slug":"category-43138"},"buildId":"1bBCYhXOG7wsYuaBifvjK","isFallback":false,"gsp":true,"scriptLoader":[]}</script></body></html>

Pages: 1 2 3 4 5 6 7 8 9 10